feed,title,long_url,short_url
BioRxiv,An intranasal ASO therapeutic targeting SARS-CoV-2,https://biorxiv.org/cgi/content/short/2021.05.17.444397v1?rss=1,https://j.mp/3fuQMsd
BioRxiv,Effects of common mutations in the SARS-CoV-2 Spike RBD domain and its ligand the human ACE2 receptor on binding affinity and kinetics,https://biorxiv.org/cgi/content/short/2021.05.18.444646v1?rss=1,https://j.mp/3wi5PfE
BioRxiv,"SARS-like coronaviruses in horseshoe bats (Rhinolophus spp.) in Russia, 2020",https://biorxiv.org/cgi/content/short/2021.05.17.444362v1?rss=1,https://j.mp/3eYEKsb
BioRxiv,Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice,https://biorxiv.org/cgi/content/short/2021.05.18.444622v1?rss=1,https://j.mp/3yoHfLW
BioRxiv,In Silico Molecular-Based Rationale for SARS-CoV-2 Spike Circulating Mutations Able to Escape Bamlanivimab and Etesevimab Monoclonal Antibodies,https://biorxiv.org/cgi/content/short/2021.05.18.444605v1?rss=1,https://j.mp/3uUrRF7
